Although alterations of Gpx2 and Duox2 expression were most evident in PL or RT/TMZ/PL group, only SOD2 among all the 27 ROSgen/ROSsca genes showed significant correlation to OS of GBM patients (Supplementary Fig. 5). This evidence concerns the gene SOD2 and glioblastoma.